Regulators on the Verge of Bungling Drug Price Reform, Advocates Say

The starting point for negotiations with drug companies on prescription prices could end up being the too-high prices patients already live with.


You can count on the Prospect, can we count on you?

There's no paywall here. Your donations power our newsroom as we report on ideas, politics and power — and what’s really at stake as we navigate another presidential election year. Please, become a member, or make a one-time donation, today. Thank you!